acetaminophen Side Effects
Also known as: Tylenol
Analysis of 417,458 adverse event reports submitted to the FDA from 1998 to 2025.
Total Reports
417,458
Death-Related
58,910
14.1% of reports
Hospitalizations
150,224
36.0% of reports
Top Indication
Product Used For Unknown Indication
Most Reported Adverse Reactions
Who Reports Side Effects
Gender Distribution
Age Distribution
Reporting Trend by Year
Reactions in Death Reports
Top reactions reported in 58,910 reports where death was an outcome. These are voluntarily reported and do not establish causation.
| Reaction | Reports |
|---|---|
| DEATH | 14,850 |
| COMPLETED SUICIDE | 8,093 |
| TOXICITY TO VARIOUS AGENTS | 7,950 |
| OFF LABEL USE | 4,372 |
| FATIGUE | 3,857 |
| PNEUMONIA | 3,569 |
| DYSPNOEA | 3,501 |
| VOMITING | 3,339 |
| NAUSEA | 3,268 |
| DIARRHOEA | 3,160 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 2,976 |
| PYREXIA | 2,871 |
| PAIN | 2,861 |
| ASTHENIA | 2,838 |
| HEADACHE | 2,678 |
| HYPERTENSION | 2,663 |
| ARTHRALGIA | 2,510 |
| CONFUSIONAL STATE | 2,459 |
| MALAISE | 2,455 |
| DECREASED APPETITE | 2,404 |
Reactions in Hospitalization Reports
Top reactions in 150,224 reports where hospitalization was an outcome.
| Reaction | Reports |
|---|---|
| NAUSEA | 12,446 |
| FATIGUE | 11,938 |
| PNEUMONIA | 11,247 |
| DYSPNOEA | 11,212 |
| VOMITING | 11,193 |
| OFF LABEL USE | 11,155 |
| PYREXIA | 10,991 |
| PAIN | 10,516 |
| DIARRHOEA | 10,311 |
| HEADACHE | 9,240 |
| TOXICITY TO VARIOUS AGENTS | 8,965 |
| FALL | 8,648 |
| ASTHENIA | 8,352 |
| DRUG INEFFECTIVE | 8,061 |
| ARTHRALGIA | 7,726 |
| MALAISE | 7,238 |
| DIZZINESS | 6,552 |
| ABDOMINAL PAIN | 6,540 |
| HYPOTENSION | 6,215 |
| RASH | 6,000 |
Nearby — Related Medications
What the FAERS Data Reveals About acetaminophen Side Effects
The FDA Adverse Event Reporting System (FAERS) contains 417,458 voluntary reports linked to acetaminophen and its brand equivalents (Tylenol), spanning 1998 through 2025. Of those, 58,910 (14.1%) listed death as an outcome and 150,224 (36.0%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.
Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 65% were female and 35% male; age distribution skews toward 45-64, with 84,726 reports in that bracket. The single most reported reaction is fatigue with 34,487 submissions, followed by drug ineffective and off label use.
FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice — speak with a licensed clinician about any side-effect concerns.
Read our methodology — how this data is sourced, computed, and verified.